01/18/2018
One new Vanderbilt technology earned patent protection in December
9,844,542 Substituted imidazopyridine and triazolopyridine compounds as negative allosteric modulators of mGluR5
One new Vanderbilt technology earned patent protection in December
9,844,542 Substituted imidazopyridine and triazolopyridine compounds as negative allosteric modulators of mGluR5